BeSpoke Decision Support for Patients With Newly Diagnosed Localised Prostate Cancer
This is not medical advice. AI-assisted translation — inaccuracies may occur. Always verify the original and consult your oncologist before taking any steps.
About the trial
The goal of this randomised clinical trial is to assess whether personalised treatment counselling can improve the decision-making experience in patients with a new diagnosis of localised prostate cancer. The main question it aims to answer is: • Does the Bespoke Decision Support tool reduce decisional conflict in those choosing between treatment options for localised prostate cancer? Researchers will compare the addition of the Bespoke Decision Support tool to standard treatment counselling versus standard counselling alone. Patient participants will: * Receive standard counselling with or without access to the Bespoke Decision Support tool (based on arm of randomisation), prior to making a treatment decision. * Answer to questionnaires regarding urinary, sexual and bowel function and decision-making outcomes before and after making a treatment decision and at 3, 6, and 12 months after initiating treatment. * Take part in a qualitative interview to discuss their decision-making experience Health Care Professional participants will: • Take part in a qualitative interview to discuss their experience in providing decision support in the trial using the Bespoke Decision Support tool.
Original English text from ClinicalTrials.gov
Who can (and can't) join
✓ Qualifies
- •Nowo zdiagnozowany rak prostaty z ograniczonym zasięgiem.
- •Pacjent może wybrać co najmniej dwie z opcji leczenia: obserwację, terapię celowaną, usunięcie prostaty, radioterapię.
- •Pacjent rozumie i zgadza się na udział w badaniu.
✗ Disqualifies
- •Rak prostaty o bardzo niskim ryzyku lub inne poważne problemy zdrowotne uniemożliwiające leczenie.
- •Podejrzenie, że rak prostaty rozsiał się po organizmie.
- •Pacjent nie może wyrazić świadomej zgody.
- •Pacjent nie mówi wystarczająco po angielsku, aby korzystać z narzędzia wsparcia (chyba że ma pomoc rodziny/przyjaciół).
Simplified criteria — AI translation
Trial details
- Last updated (source)
- July 29, 2026
- Sex
- No restrictions
Therapies / drugs in trial
Locations (1)
University College London Hospitals NHS Foundation Trust
London, United Kingdom
Trial contact
Davide Maffei, MD
NCITA Clinical Trial Unit
Contact information from ClinicalTrials.gov. Contact in English.
Share this trial
Data from ClinicalTrials.gov. AI-assisted translation, last sync: 7/31/2026.
You can help another person
We fund the Radar, this site, and the development of our Grosz dla Życia fundraising platform from donations and our own resources. Every contribution, even a small one, really helps.